Navigation Links
RXi Pharmaceuticals Announces mRNA Data of an Additional Cohort in the Second Phase 1 Multi-Dose Study with RXI-109, Extending the Dose Response Following Treatment in the Initial 2-week Period
Date:12/4/2013

WESTBOROUGH, Mass., Dec. 4, 2013 /PRNewswire/ -- RXi Pharmaceuticals Corporation (OTCQX: RXII), a biotechnology company focused on discovering, developing and commercializing innovative therapies addressing major unmet medical needs using RNA-targeted technologies, today announced additional results from their second placebo-controlled Phase 1 study with RXI‑109, an sd-rxRNA® compound that targets Connective Tissue Growth Factor (CTGF), and is being developed for the treatment of abnormal dermal scars such as hypertrophic scars and keloids in conjunction with scar revision surgery.

(Logo:  http://photos.prnewswire.com/prnh/20130917/NE80755LOGO )

In this study, subjects received small skin incisions in their abdomen and were treated with three intradermal doses of RXI‑109 over a 2-week period.  The dose escalating portion of the study consisted of four cohorts of three healthy volunteers each.  An additional 5th cohort was also added at the highest dose, in which the treatment period was delayed by two weeks. Subjects received RXI‑109 on one side of the abdomen, and placebo on the other side. Subjects were monitored for safety and local and systemic side effects over a total study period of 84 days. Multiple dermal injections were well tolerated at all doses, and treatment with RXI‑109 resulted in dose-dependent silencing of CTGF mRNA in the treated areas. In the additional 4th cohort of this study, three doses of 10 mg dose per incision over the initial 2-week period following the incision averaged approximately 50% reduction of CTGF mRNA expression compared to placebo when measured three days after the last dose. In the 5th cohort, where the dosing period with 10 mg RXI-109 per incision was delayed by 2 weeks after the incisions were made, no additional benefit was seen on m
'/>"/>

SOURCE RXi Pharmaceuticals Corporation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Savient Pharmaceuticals to Hold First Quarter 2012 Financial Results Conference Call on Wednesday, May 9, 2012
2. Auxilium Pharmaceuticals to Present at the Deutsche Bank 37th Annual Healthcare Conference
3. Nouveau Life Pharmaceuticals (HRID) Contracts with U.S. Manufacturer to Produce New Female Supplement
4. BioElectronics Survey Indicates a Five-Fold Superior Pain Relief Compared to OTC Pharmaceuticals
5. Icahn Issues Statement Regarding Amylin Pharmaceuticals
6. Almost 50 Percent of the Glaucoma Patient Population Remains Untreated, Signifying a Vast Market for Glaucoma Pharmaceuticals, Finds Frost & Sullivan
7. Omthera Pharmaceuticals Announces Positive Top-Line Results from Phase 3 EVOLVE Study
8. Onyx Pharmaceuticals Announces FDA Advisory Committee to Review Carfilzomib for the Treatment of Patients with Relapsed and Refractory Multiple Myeloma
9. Jazz Pharmaceuticals Announces First Quarter 2012 Financial Results Conference Call On May 8, 2012
10. Inovio Pharmaceuticals Granted U.S. Patent Protection for Synthetic Vaccine for Cervical Dysplasia and Cancer
11. Avanir Pharmaceuticals To Present at Three Conferences In May
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2014)... , Aug. 28, 2014 Nonin Medical, Inc., ... in noninvasive medical monitoring, today announced that the Food ... 3231 OEM/eHealth finger pulse oximeter for use in ... oximeter plugs into a telemedicine hub or kiosk through ... rate in pediatric to adult patients. The Model 3231 ...
(Date:8/28/2014)... , Aug. 28, 2014  In recognition of the ... complications from the flu, pneumonia, shingles and other ... have declared September to be Senior Vaccination Month. ... it is important that adults ages 65 years ... vaccinations. CVS pharmacists and MinuteClinic nurse practitioners and ...
(Date:8/28/2014)... , Aug. 28, 2014  Robotic surgery is ... media, both for the promise of improved outcomes ... quick deployment of surgical robots and market pressures ... facilities to evaluate their robotic surgery training programs ... team.    ECRI Institute ( www.ecri.org ...
Breaking Medicine Technology:Nonin Medical Announces FDA Clearance of Nonin Model 3231 USB Pulse Oximeter 2September is Senior Vaccination Month at CVS/pharmacy and MinuteClinic 2September is Senior Vaccination Month at CVS/pharmacy and MinuteClinic 3September is Senior Vaccination Month at CVS/pharmacy and MinuteClinic 4Surgical Robot Risk and Safety: ECRI Institute and Hartford Hospital Launch New Education Series 2Surgical Robot Risk and Safety: ECRI Institute and Hartford Hospital Launch New Education Series 3Surgical Robot Risk and Safety: ECRI Institute and Hartford Hospital Launch New Education Series 4Surgical Robot Risk and Safety: ECRI Institute and Hartford Hospital Launch New Education Series 5
... Jan. 25 Richard Cooper Woodyard , Vice ... January 19th after a 2-year fight with cancer. ... eCardio as Vice President, Business Development. As Vice President, Sales, ... responsible for identifying, negotiating and integrating new partners, products, technologies, ...
... , SOUTH SAN FRANCISCO, Calif. , ... announced today that Institutional Shareholder Services/Risk Metrics Group (ISS) and ... advisory firms, recommend that VaxGen stockholders vote "FOR" the proposed ... Proposal to adjourn the VaxGen special meeting, if necessary, to ...
Cached Medicine Technology:Richard Woodyard, Vice President of Sales at eCardio, Loses Fight Against Cancer 2ISS/Risk Metrics Group and Glass Lewis Recommend VaxGen Stockholders Vote 'For' Proposed Merger With OXiGENE 2ISS/Risk Metrics Group and Glass Lewis Recommend VaxGen Stockholders Vote 'For' Proposed Merger With OXiGENE 3ISS/Risk Metrics Group and Glass Lewis Recommend VaxGen Stockholders Vote 'For' Proposed Merger With OXiGENE 4ISS/Risk Metrics Group and Glass Lewis Recommend VaxGen Stockholders Vote 'For' Proposed Merger With OXiGENE 5
(Date:8/29/2014)... 29, 2014 Hope For The Warriors® ... Spouse/Caregiver Scholarships. Scholarships are awarded two times each year ... to spouses of fallen service members. Hope For The ... sense of self, restoring the family unit, and restoring ... , The Spouse/Caregiver Scholarship Program identifies, recognizes, and ...
(Date:8/29/2014)... Boca Raton, Florida (PRWEB) August 29, 2014 ... in which surgeons, like Dr. Scott Katzman of ... endoscopic instruments to view and perform repairs. Problems ... around the vertebrae cause a number of treatment needs ... This type spine surgery involves an advantageously small incision ...
(Date:8/29/2014)... Stamford, CT (PRWEB) August 29, 2014 ... that firm founder Russell J. Berkowitz was included in ... of Best Lawyers® in America. Best Lawyers® is the ... U.S. and beyond. , An inclusion in Best ... community as it only lists attorneys who have earned ...
(Date:8/29/2014)... Asheville, NC (PRWEB) August 29, 2014 ... District in the North Carolina General Assembly, spent the ... Aeroflow Healthcare and touring our facilities. , Representative Moffitt’s ... Asheville based durable medical equipment (DME) company and to ... could impact DME providers such as Aeroflow. , ...
(Date:8/29/2014)... (PRWEB) August 29, 2014 http://www.fdanews.com/CTMPR ... of Clinical Trials Magnifier Weekly. , Clinical Trial Magnifier ... world every week and reports all the fresh changes. ... is able to extract just the information readers need. ... drill down using links in the newsletter to focus ...
Breaking Medicine News(10 mins):Health News:Hope For The Warriors Announces Fall 2014 Spouse/Caregiver Scholarship Recipients 2Health News:Hope For The Warriors Announces Fall 2014 Spouse/Caregiver Scholarship Recipients 3Health News:Advancements in Spine Surgery Offered by this Modern Florida Surgery Group are Cutting Out Historically Demanding Recovery Times 2Health News:Russell J. Berkowitz, Esq. of The Berkowitz Law Firm LLC Selected by Best Lawyers® for Personal Injury Litigation 2Health News:North Carolina Representative Tim Moffitt Visits Aeroflow Healthcare 2Health News:FDAnews Accounces New Newsletter: Clinical Trial Magnifier Weekly Provides the Most Up-to-Date Clinical Trial Data 2Health News:FDAnews Accounces New Newsletter: Clinical Trial Magnifier Weekly Provides the Most Up-to-Date Clinical Trial Data 3Health News:FDAnews Accounces New Newsletter: Clinical Trial Magnifier Weekly Provides the Most Up-to-Date Clinical Trial Data 4
... for May 12, 2008 at 1:30 p.m. (Pacific); ... webcast at http://www.adventrx.com , SAN DIEGO, May 5 ... it will host a conference call with,simultaneous webcast to discuss ... p.m. Pacific / 4:30 p.m. Eastern. Evan M. Levine, Chief,Executive ...
... Veterinary Medical,Association (AVMA) reiterated today, at the start ... veterinarians working in the,public sector and urged Congress ... Veterinarians fill essential positions at agencies, including ... of Agriculture,the US Food and Drug Administration and ...
... Mich.---A new study suggests that extra iron for infants who ... the debate over optimal iron supplement levels and could have ... "Our results for 25 years of research show problems with ... a big deal, it,s really unexpected," said Dr. Betsy Lozoff, ...
... LATEST REVIEW SUGGESTS LABAs ARE SAFE AND EFFECTIVE FOR ... of long-acting β2-agonists (LABA) to increased risk for adverse ... to severe chronic obstructive pulmonary disease (COPD); however, a ... In a new metaanalysis, researchers from Spain, Argentina, and ...
... York, NY A preliminary analysis of ongoing research suggests that ... BRCA1/2 mutation may face a greater chance for developing a ... risk of cancer in these women, should sentinel node biopsy ... can women best be counseled after these findings? , ...
... help bridge this knowledge gap, experts say , , SUNDAY, ... babies have a surprisingly low knowledge of child development, ... or how they should act, a new study finds. ... don,t know that 1-year-olds can,t tell the difference between ...
Cached Medicine News:Health News:AVMA Recognizes Public Veterinarians Urges Congressional Action 2Health News:Iron supplements might harm infants who have enough 2Health News:News briefs: May issue of the journal Chest 2Health News:Second breast cancer may be greater than thought for high-risk women without BRCA mutations 2Health News:One-Third of Parents Lack Facts About Child Development 2Health News:One-Third of Parents Lack Facts About Child Development 3
... nebulizers offer a spill-proof design and effective ... 45° angle. All medical nebulizers are free-standing ... of configurations are available., ,All Portex® ... ,Portex® medication nebulizers feature consistently fine misting ...
... medication as well as humidification, try Flo-Mist™., ... high volume, continuous medication nebulizer (CMN), engineered ... Its 200 ml reservoir and jet flow ... of nebulized medication delivery at 25 ml/hr. ...
Infant Nebulizer Kit W/Misty-Nebulizer 30/CS CE Mark Only...
... and Respiratory Products, ,Westmed designs, manufacturers ... Anesthesia and Respiratory professionals. Our mission is ... the clinician's ability to deliver quality medical ... bottom line. , ,Our web site ...
Medicine Products: